Teladoc Health, Inc. (TDOC): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$743.99M
Year ended 2022-12-31
+59.2%
3-year compound annual growth
+64.6%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $743.99M | +14.4% | 2023-03-01, From 2022-01-01 |
| 2021-12-31 | $650.26M | +66.4% | 2023-03-01, From 2021-01-01 |
| 2020-12-31 | $390.83M | +111.9% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $184.47M | +43.3% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $128.74M | +108.9% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $61.62M | +92.7% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $31.97M | +51.9% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $21.04M | +111.9% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $9.93M | +137.2% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $4.19M | n/a | 2016-03-03, From 2013-01-01 |